Indication
Cholecystitis
Cholecystitis is an acute or chronic inflammatory disease of the biliary system characterized by inflammation of the gallbladder wall. Read more about Cholecystitis
10 drugs 9 manufacturers
Drugs that treat it
Common Cholecystitis therapies.
DORIBAX (doripenem)
TYGACIL (tigecycline)
DORIPENEM
TYGACIL (tigecycline)
TIGECYCLINE
TIGECYCLINE
TIGECYCLINE
TIGECYCLINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCholecystitis is an acute or chronic inflammatory disease of the biliary system characterized by inflammation of the gallbladder wall.
It predominantly affects adults, with an elevated risk among females and individuals with preexisting gallstones, though it can also arise in critically ill populations without cholelithiasis.
The condition most commonly develops when a gallstone obstructs the cystic duct, causing bile stasis, mucosal irritation, elevated intraluminal pressure, ischemia, and potentially secondary bacterial infection.
Clinically, it manifests with persistent right upper quadrant or epigastric abdominal pain—often radiating to the back or right shoulder—accompanied by local tenderness, fever, leukocytosis, and nausea.
- nih.gov
Cholecystitis is an acute or chronic inflammatory disease of the biliary system characterized by inflammation of the gallbladder wall The condition most commonly develops when a gallstone obstructs the cystic duct, causing bile stasis, mucosal irritation, elevated intraluminal pressure, ischemia, and potentially secondary bacterial infection
- nih.gov
Cholecystitis is an acute or chronic inflammatory disease of the biliary system characterized by inflammation of the gallbladder wall Clinically, it manifests with persistent right upper quadrant or epigastric abdominal pain—often radiating to the back or right shoulder—accompanied by local tenderness, fever, leukocytosis, and nausea
- nih.gov
It predominantly affects adults, with an elevated risk among females and individuals with preexisting gallstones, though it can also arise in critically ill populations without cholelithiasis
- nih.gov
It predominantly affects adults, with an elevated risk among females and individuals with preexisting gallstones, though it can also arise in critically ill populations without cholelithiasis
- nih.gov
It predominantly affects adults, with an elevated risk among females and individuals with preexisting gallstones, though it can also arise in critically ill populations without cholelithiasis Clinically, it manifests with persistent right upper quadrant or epigastric abdominal pain—often radiating to the back or right shoulder—accompanied by local tenderness, fever, leukocytosis, and nausea
- nih.gov
The condition most commonly develops when a gallstone obstructs the cystic duct, causing bile stasis, mucosal irritation, elevated intraluminal pressure, ischemia, and potentially secondary bacterial infection
- medlineplus.gov
The condition most commonly develops when a gallstone obstructs the cystic duct, causing bile stasis, mucosal irritation, elevated intraluminal pressure, ischemia, and potentially secondary bacterial infection
Personalize your experience
Follow Cholecystitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.